ROCKET AF: A clinical Research Opportunity for People with an Irregular Heart Rhythm called Atrial Fibrillation. Atrial fibrillation (Afib) and risk of stroke—the serious side to having a heart that flutters...

What is Atrial fibrillation?

Atrial fibrillation (Afib) is when the heart beats irregularly and more rapidly than normal, also known as arrhythmia. Afib is the most common type of arrhythmia and can increase the risk of blood clots that cause stroke. A clinical research study is evaluating a new investigational medication designed to reduce the risk of blood clot formation that can lead to stroke.

People with Afib and at risk of blood clot formation are usually treated with blood thinners; one of the most frequently prescribed is warfarin (Coumadin®). While warfarin is effective at reducing the risk of blood clot formation, researchers are trying to develop more convenient treatments. A study called ROCKET AF is now underway to evaluate a new investigational medication and is looking for volunteers— could you take part?